Records containing: Hepatocellular Carcinoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-05-19Immunomonitoring of Interventional Radiology Procedures in the Management of Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2021-05-06Characterization of Methylation Patterns in Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2021-05-06Randomized, Controlled, Open Label, Clinical Trial for Adagloxad Simolenin/OBI-821 in Combination With TACE Therapy in Hepatocellular Carcinoma Patients With GALNT14-rs9679162-non-TT Genotype
-
CLINICAL_TRIALS study record update · 2021-05-03A Single-Arm Open-Label Pilot Study of Combination Therapy of TACE and Ablation With Durvalumab in A Selected Hepatocellular Carcinoma Population at Intermediate Stage
-
CLINICAL_TRIALS study record update · 2021-04-28Hepatic Arterial Blood Flow Modulation in Patients With Hepatocellular Carcinoma: Influence of Intra-arterial Norepinephrine Assessed With CT Perfusion
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-04-23Transarterial Infusion of PD-1 Antibody Plus Chemoembolization and FOLFOX-based Chemtherapy for Unresectable BCLC C Stage HCC: a Single-arm, Phase 2 Clinical Trial
-
CLINICAL_TRIALS study record update · 2021-04-21A TheraSphere® Advanced Dosimetry Retrospective Global Study Evaluation in Hepatocellular Carcinoma Treatment
-
CLINICAL_TRIALS study record update · 2021-04-19Evaluation of Gd-EOB-DTPA MRI for Detection and Characterization of Liver Nodules in Cirrhotic Patients Undergoing Liver Transplantation and Potential Impact on Transplant Eligibility
-
CLINICAL_TRIALS study record update · 2021-04-14An Exploratory Study of Sintilimab in Combination With Bevacizumab Biosimilar in Patients With Potentially Resectable Intermediate HCC
-
CLINICAL_TRIALS study record update · 2021-04-14Assessment of the Real-time CT/MR-US Automatic Fusion System Using Vascular Matching in Pre-procedure Planning for Radiofrequency Ablation: Preliminary Study
-
CLINICAL_TRIALS study record update · 2021-04-09An Open-label, Single-institution, Non-randomized, Single-arm, Pilot Study of Jiu-wei-zhen-xiao Granule for the Treatment in Patients With Advanced Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2021-04-08An Open-Label, Multicenter, Randomized, Phase Ib/II Study of E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Patients With Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2021-04-06A Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients With Epithelial Cancer
-
CLINICAL_TRIALS study record update · 2021-04-06A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®
-
CLINICAL_TRIALS study record update · 2021-04-02Microwave Ablation of Resectable Liver Tumors
-
CLINICAL_TRIALS study record update · 2021-04-01Camrelizumab Combined Apatinib in Patients With Hepatocellular Carcinoma Previously Treated With Immune Checkpoint Inhibitors: A Single-Arm, Open-Label, Phase II Study.
-
CLINICAL_TRIALS study record update · 2021-04-01Surgical Therapy and Survival in Young Patients With Stage I-II Hepatocellular Carcinoma: A Retrospective Cohort Study
-
CLINICAL_TRIALS study record update · 2021-03-30Prospective, Multicenter, Non Randomized, Single Arm Study to Evaluate Safety of Transarterial Chemoembolization (TACE) With Doxorubicin Eluting 100 µ Microspheres in Patients With Non Resectable Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2021-03-29Phase 1, Open-label, Three Routes IV, Intratumoral Injections and Intra-hepatic Artery Dose-escalation Clinical Study to Evaluate the Safety and Efficacy of ET1402L1-ARTEMIS™2™ T- Cells in AFP Expressing Hepatocellular Carcinoma (HCC)
-
CLINICAL_TRIALS study record update · 2021-03-26Irreversible Electroporation of Unresectable Liver Tumors - a Phase I Study of Safety and Feasibility
-
CLINICAL_TRIALS study record update · 2021-03-24Sequential Treatment of Hepatocellular Carcinoma by Transarterial Chemoembolization and Local Ablation or External Radiation
-
CLINICAL_TRIALS study record update · 2021-03-23Effect of Stereotactic Body Radiotherapy Followed by Sintilimab Versus Stereotactic Body Radiotherapy Alone for Hepatocellular Carcinoma With Portal Vein Invasion After Arterially Directed Therapy: A Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2021-03-23Radiofrequency Ablation Using Octopus Electrodes for Small Hepatocellular Carcinoma With No-touch Technique: A Prospective Single Arm Study
-
CLINICAL_TRIALS study record update · 2021-03-17Comparison of Biannual Ultrasonography and Annual Unenhanced Magnetic Resonance Imaging as a Surveillance Test for HCC in Patients With Liver Cirrhosis
-
CLINICAL_TRIALS study record update · 2021-03-17Evaluation of Diagnostic Accuracy of Contrast-enhanced Ultrasound (CEUS) and Gadoxetic Acid-enhanced Liver MRI for Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis